Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Harpoon Therapeutics Inc
(NQ:
HARP
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EST, Mar 8, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
-
Bid (Size)
23.00 (6)
Ask (Size)
23.01 (36)
Prev. Close
23.01
Today's Range
N/A - N/A
52wk Range
0.7939 - 23.21
Shares Outstanding
37,595,787
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Analyst Scoreboard: 4 Ratings For Harpoon Therapeutics
February 26, 2024
Via
Benzinga
Harpoon Therapeutics Inc. (NASDAQ: HARP) Records 52-Week High Thursday Morning
February 22, 2024
Via
Investor Brand Network
Performance
More News
Read More
Merck Posts Surprise Quarterly Profit Against An Expected Loss, Oncology And Vaccines Drive Growth
February 01, 2024
Via
Benzinga
Investor Optimism Around Keytruda Drives Merck Stock To Golden Cross Ahead of Earnings
January 29, 2024
Via
Benzinga
This 1 Bullish Move by Merck Could Drive Growth for Years to Come
January 23, 2024
Via
The Motley Fool
The 3 Best Dividend Growth Stocks to Buy in January 2024
January 17, 2024
Via
InvestorPlace
Peeling Back The Layers: Exploring Harpoon Therapeutics Through Analyst Insights
January 16, 2024
Via
Benzinga
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Ambrx Biopharma, Inc. (Nasdaq – AMAM), Gracell Biotechnologies Inc. (Nasdaq – GRCL), Axonics, Inc. (Nasdaq - AXNX), Harpoon Therapeutics, Inc. (Nasdaq - HARP)
January 16, 2024
From
Brodsky & Smith LLC
Via
GlobeNewswire
Stock Market Rally Rebounds; Nvidia, Tesla, JPMorgan, Bitcoin ETFs In Focus: Weekly Review
January 12, 2024
Via
Investor's Business Daily
Topics
ETFs
HARPOON THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Harpoon Therapeutics, Inc. - HARP
January 10, 2024
From
Kahn Swick & Foti, LLC
Via
Business Wire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Ambrx Biopharma, Inc. (Nasdaq – AMAM), Gracell Biotechnologies Inc. (Nasdaq – GRCL), Axonics, Inc. (Nasdaq - AXNX), Harpoon Therapeutics, Inc. (Nasdaq - HARP)
January 08, 2024
From
Brodsky & Smith LLC
Via
GlobeNewswire
Dow Surges Over 100 Points; Commercial Metals Posts Upbeat Q1 Results
January 08, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why RxSight Shares Are Trading Higher By 20%? Here Are Other Stocks Moving In Monday's Mid-Day Session
January 08, 2024
Via
Benzinga
Harpoon Therapeutics Inc. (NASDAQ: HARP) Near the Top of Equities by Percentage Gain on 1/8
January 08, 2024
Via
Investor Brand Network
12 Health Care Stocks Moving In Monday's Intraday Session
January 08, 2024
Via
Benzinga
Crude Oil Falls Sharply; Ambrx Biopharma Shares Spike Higher
January 08, 2024
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
Today Is Cancer-Focused Deals Day: Johnson & Johnson Scoops Up Ambrx Biopharma As Merck Boosts Cancer Portfolio With Harpoon Deal
January 08, 2024
Via
Benzinga
Health Care Company Merck & Co Announces Acquisition of Harpoon Therapeutics
January 08, 2024
Via
Benzinga
US Stocks Mixed; Nasdaq Jumps Over 100 Points
January 08, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Merck, the Dow's hottest stock, gets set to report Q4 financials
January 08, 2024
Via
MarketBeat
Topics
Stocks
Exposures
US Equities
J&J, Merck, Boston Scientific Debut Trio Of Splashy Takeovers Topping $3 Billion In Value
January 08, 2024
Via
Investor's Business Daily
Why Is Spirit AeroSystems (SPR) Stock Down 14% Today?
January 08, 2024
Via
InvestorPlace
Why Is LumiraDx (LMDX) Stock Down 13% Today?
January 08, 2024
Via
InvestorPlace
Why Is Cellectar Biosciences (CLRB) Stock Up 16% Today?
January 08, 2024
Via
InvestorPlace
HARP Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Harpoon Therapeutics, Inc. Is Fair to Shareholders
January 08, 2024
From
Halper Sadeh LLC
Via
Business Wire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.